Related Experiment Videos

[A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method]

Hiroko Yoshida1, Hiromi Ano, Chieko Ishida

  • 1Department of Clinical Pathology Laboratory, Osaka Prefectural Habikino Hospital, 3-7-1, Habikino, Habikino-shi, Osaka 583-8588, Japan. ZUM11464@nifty.ne.jp

Kekkaku : [Tuberculosis]
|August 22, 2002
PubMed

Insights

Tuberculosis strains resistant to 0.1 microgram/ml of isoniazid (INH) are clinically significant. These INH-resistant Mycobacterium tuberculosis strains demonstrate higher minimum inhibitory concentrations, confirming resistance and impacting patient treatment strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Context:

  • The Ogawa egg-based medium uses 0.1, 1, or 5 micrograms/ml of isoniazid (INH) for antimycobacterial susceptibility testing.
  • A critical concentration of 1 microgram/ml is used to define INH resistance.
  • Clinical significance of INH resistance at 0.1 microgram/ml remains controversial.

Purpose:

  • To investigate the minimum inhibitory concentration (MIC) values of INH 0.1 microgram/ml resistant Mycobacterium tuberculosis strains.
  • To determine the clinical significance of INH resistance at lower concentrations using the BrothMIC MTB-1 method.

Summary:

  • 115 DNA-proven Mycobacterium tuberculosis strains were tested.
  • The BrothMIC MTB-1 method classified strains into susceptible, low resistant, and high resistant groups.
  • INH 0.1 microgram/ml resistant strains had a mean MIC of 4.53 micrograms/ml, classifying them as resistant by the BrothMIC MTB-1 method.

Impact:

  • Results support classifying patients with INH 0.1 microgram/ml resistant M. tuberculosis strains as clinically resistant.
  • This finding aids in refining treatment guidelines for tuberculosis.
  • Improved management of drug-resistant tuberculosis cases.

Related Concept Videos